Invention Grant
- Patent Title: Buprenorphine-wafer for drug substitution therapy
-
Application No.: US15135794Application Date: 2016-04-22
-
Publication No.: US09861628B2Publication Date: 2018-01-09
- Inventor: Alexander Oksche , William Heath , Timothy Holden , Derek A. Prater , Richard S. Sackler , Malcolm Walden
- Applicant: Rhodes Pharmaceuticals L.P.
- Applicant Address: US RI Coventry
- Assignee: RHODES PHARMACEUTICALS L.P.
- Current Assignee: RHODES PHARMACEUTICALS L.P.
- Current Assignee Address: US RI Coventry
- Agency: Sterne, Kessler, Goldstein & Fox PLLC
- Priority: EP06119839 20060830
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/485 ; A61K47/38 ; A61K9/00 ; A61K9/70
Abstract:
The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.
Public/Granted literature
- US20160235739A1 BUPRENORPHINE WAFER FOR DRUG SUBSTITUTION THERAPY Public/Granted day:2016-08-18
Information query
